Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.41
0.04 (1.19%)
At close: May 09, 2025, 9:42 AM
1.19%
Bid 3.35
Market Cap 131.55M
Revenue (ttm) n/a
Net Income (ttm) -44.6M
EPS (ttm) -2.17
PE Ratio (ttm) -1.57
Forward PE -1.6
Analyst Buy
Ask 3.4
Volume 13,082
Avg. Volume (20D) 357,950
Open 3.37
Previous Close 3.37
Day's Range 3.34 - 3.49
52-Week Range 1.59 - 10.48
Beta 1.72

About TARA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
-18.52%
Protara Therapeutics shares are trading lower. The... Unlock content with Pro Subscription
2 weeks ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.